BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 14629731)

  • 21. Stereoselectivity in drug metabolism and action: effects of enzyme inhibition and induction.
    Kroemer HK; Fromm MF; Eichelbaum M
    Ther Drug Monit; 1996 Aug; 18(4):388-92. PubMed ID: 8857556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Membrane Bioreactors for Pharmaceutical Applications: Optically Pure Enantiomers Production.
    Piacentini E; Mazzei R; Giorno L
    Curr Pharm Des; 2017; 23(2):250-262. PubMed ID: 27881063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The strategy of enantiomer patents of drugs.
    Agranat I; Wainschtein SR
    Drug Discov Today; 2010 Mar; 15(5-6):163-70. PubMed ID: 20116449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Chiral switch: towards a better benefit-risk ratio?].
    Blin O
    Therapie; 2004; 59(6):625-8. PubMed ID: 15789826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug chirality and its clinical significance.
    Hutt AJ; Tan SC
    Drugs; 1996; 52 Suppl 5():1-12. PubMed ID: 8922553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The importance of stereoselective determination of drugs in the clinical laboratory.
    Rentsch KM
    J Biochem Biophys Methods; 2002 Dec; 54(1-3):1-9. PubMed ID: 12543488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cost benefit ratio of enantiomeric drugs.
    Pifferi G; Perucca E
    Eur J Drug Metab Pharmacokinet; 1995; 20(1):15-25. PubMed ID: 7588989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Three-dimensional view of pharmacology.
    Wainer IW
    Am J Hosp Pharm; 1992 Sep; 49(9 Suppl 1):S4-8. PubMed ID: 1530004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analytical and Preparative Scale Separation of Enantiomers of Chiral Drugs by Chromatography and Related Methods.
    Gumustas M; Ozkan SA; Chankvetadze B
    Curr Med Chem; 2018; 25(33):4152-4188. PubMed ID: 29376488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The market of chiral drugs: Chiral switches versus de novo enantiomerically pure compounds.
    Calcaterra A; D'Acquarica I
    J Pharm Biomed Anal; 2018 Jan; 147():323-340. PubMed ID: 28942107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The development of single-isomer molecules: why and how.
    Hutt AJ
    CNS Spectr; 2002 Apr; 7(4 Suppl 1):14-22. PubMed ID: 15131488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enantiomers: implications and complications in developmental pharmacology.
    Eichelbaum M
    Dev Pharmacol Ther; 1992; 18(3-4):131-4. PubMed ID: 1306801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential properties of enantiomers of commercially available racemates.
    Gulati V
    J Indian Med Assoc; 2007 Apr; 105(4):173-4, 176. PubMed ID: 17822184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enantiomer separation of drugs by capillary electromigration techniques.
    Blaschke G; Chankvetadze B
    J Chromatogr A; 2000 Apr; 875(1-2):3-25. PubMed ID: 10839137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of stereoselectivity on the pharmacokinetics and pharmacodynamics of antiarrhythmic drugs.
    Mehvar R; Brocks DR; Vakily M
    Clin Pharmacokinet; 2002; 41(8):533-58. PubMed ID: 12102640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stereoisomers and drug toxicity. The value of single stereoisomer therapy.
    Scott AK
    Drug Saf; 1993 Feb; 8(2):149-59. PubMed ID: 8452656
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiation of antiinflammatory and antitumorigenic properties of stabilized enantiomers of thalidomide analogs.
    Jacques V; Czarnik AW; Judge TM; Van der Ploeg LH; DeWitt SH
    Proc Natl Acad Sci U S A; 2015 Mar; 112(12):E1471-9. PubMed ID: 25775521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chirality of antidepressive drugs: an overview of stereoselectivity.
    Vashistha VK; Sethi S; Tyagi I; Das DK
    Asian Biomed (Res Rev News); 2022 Apr; 16(2):55-69. PubMed ID: 37551287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereoselective binding of chiral drugs to plasma proteins.
    Shen Q; Wang L; Zhou H; Jiang HD; Yu LS; Zeng S
    Acta Pharmacol Sin; 2013 Aug; 34(8):998-1006. PubMed ID: 23852086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stereoselective Pharmacokinetics and Chiral Inversions of Some Chiral Hydroxy Group Drugs.
    Chen F; Bai Q; Wang Q; Chen S; Ma X; Cai C; Wang D; Waqas A; Gong P
    Curr Pharm Biotechnol; 2020; 21(15):1632-1644. PubMed ID: 32718284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.